Taxanes with high potency inducing tubulin assembly overcome tumoural cell resistances

Ruth Matesanz1, Chiara Trigili1, Javier Rodríguez-Salarichs2

  • 1Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Ramiro de Maeztu 9, 28040 Madrid, Spain.

Insights

New taxane compounds overcome multiple drug resistance mechanisms in cancer cells by enhancing tubulin assembly. These modified taxanes show potent activity against resistant tumors, offering a promising avenue for chemotherapy development.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Medicinal Chemistry

Background:

  • Taxanes are crucial chemotherapy agents, but their efficacy is limited by drug resistance.
  • Mechanisms of taxane resistance include P-glycoprotein (P-gp) overexpression, β-tubulin mutations, and βIII-tubulin isotype overexpression.
  • Novel taxane derivatives are needed to overcome these resistance mechanisms.

Purpose of the Study:

  • To investigate the activity of novel taxanes with modifications at C10 and C13 positions against various taxane-resistant cancer cell lines.
  • To characterize the interaction of these active taxanes with microtubules and their cellular effects.
  • To elucidate the biochemical and thermodynamic properties underlying their enhanced efficacy.

Main Methods:

  • Synthesis and chemical modification of taxane compounds at C10 and C13 positions.
  • In vitro testing against multiple taxane-resistant cell lines (P-gp overexpression, β-tubulin mutations, βIII-tubulin overexpression).
  • Biochemical assays (tubulin assembly induction), biophysical studies (NMR, SAXS), and cellular imaging of microtubule networks.

Main Results:

  • Four modified taxanes demonstrated significant activity against all tested resistant cell lines.
  • Enhanced potency in inducing tubulin assembly was observed compared to classical taxanes.
  • Differential interaction with the microtubule S7-S9 loop (M-loop) and altered thermodynamic properties (increased hydrophilicity) were identified.
  • Distinct effects on the cellular microtubular network, including rapid nucleation and bundling, were noted.

Conclusions:

  • Chemical modifications at C10 and C13 positions yield taxanes effective against diverse taxane resistance mechanisms.
  • Enhanced tubulin assembly induction, driven by M-loop interaction and favorable thermodynamic properties, underlies their potent activity.
  • These novel taxanes represent promising candidates for developing next-generation chemotherapy agents to combat resistant cancers.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.1K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Microtubule Formation01:23

Microtubule Formation

Microtubules are dynamic structures that undergo continuous assembly and disassembly. They originate from specialized multi-protein complexes known as microtubule organizing centers or MTOCs. Within the MTOC, the point of origin of the microtubule is known as the minus end, while the end radiating outward is the plus end. Microtubules serve two primary functions — the organization of spindle complexes to separate sister chromatids during mitotic or meiotic cell division and the formation...
6.3K